States asked to stop using testing kits for 2 days amid inaccurate results in 4 States

▴ Testing kits
Rajasthan State Health Minister Raghu Sharma said, “After the test sample results, there is a question mark over the rapid test kits. We used it in the State as per ICMR guidelines but this experiment failed completely

The Indian Council of Medical Research (ICMR) on Tuesday asked the States to stop using the newly-distributed Chinese rapid testing kits (RT-PCR) meant to detect coronavirus for the next two days amid reports of inaccurate results from Rajasthan and three other States.

India procured five lakh rapid antibody testing kits from two Chinese firms last week and these were distributed to States for the districts with a high burden of the infection. As per the ICMR, variation in accuracy of results ranges from 6-71 per cent. It will be sending expert teams on fields to test the new RT-PCR kits.

“We received a complaint of less detection from one State. So we spoke to three States and found a lot of variation is there in the accuracy of test results of positive samples, in some places it is 6 per cent while others it is 71 per cent,

“We have decided to launch field studies for validation into the quality of rapid test kits. We will convey our guidance to States in two days. Until then States are advised not to use rapid kits,” head of Epidemiology and Communicable Diseases at ICMR Raman R Gangakhedkar said at a Press briefing here.

Replying to a query he said if the kits are found faulty, replacement process would be initiated.

“This is not a good thing because when such a huge variation is seen we need to investigate further even if it is the first generation of the test. This disease is only 3.5-month-old so all technologies will be refined over time but we can’t ignore these findings,” he added.

He added that over the next two days the ICMR will be sending eight expert teams on the field to validate the results.

The ICMR also said it will raise an issue with the manufacturer of the kits if results continue to be faulty.

Earlier on Tuesday, the Rajasthan Government stopped using the China-made rapid testing kits for coronavirus after they delivered inaccurate results.

The Union Health Ministry said 705 people had been cured between Monday and Tuesday — the highest single-day rise in cured cases.

Additionally, there are now four previously affected districts that have not reported any case for 28 days, said Lav Agarwal, Joint Secretary in the Health Ministry.

These are Mahe in Puducherry, Kodagu in Karnataka, Pauri Garhwal in Uttarakhand and Pratapgarh in Rajasthan.

Also, 61 districts nationally have not reported a new case for 14 days.

The official also said that, “We have issued detailed guidelines to all States that while we focus on Covid19, all other services need to be provided, be it for dialysis, HIV/cancer treatments etc. At the same time required infection management prevention should be in place.”

The kits are to be used to test people with fever, cough, and shortness of breath in 325 districts that are currently unaffected, starting with those that are in States with a high number of Covid-19 cases, explained the official, who asked not to be named. This will be the first mass testing exercise in these districts.

Rajasthan State Health Minister Raghu Sharma said, “After the test sample results, there is a question mark over the rapid test kits. We used it in the State as per ICMR guidelines but this experiment failed completely. We were hoping that the accuracy of the test will be more than 90 per cent but it was just 5 per cent. We have sent the report of the results to the ICMR. If the ICMR doesn’t provide any satisfactory response, we may send all these kits back,” he said.

www.Dailypioneer.com

Tags : #ICMR #Faulty #TestKit #Chineserapidtestingkitfails

Related Stories

20 May

CDSCO has approved Boehringer Ingelheim's Jardiance for the treatment of heart failure.

“Heart failure is a chronic condition that affects nearly 1% of India’s adult population."

View
03 Feb

European Commission approves Teysuno in metastatic colorectal cancer

Latest Corporate news updates; Pharma Feb 3rd 2022

View
03 Feb

BioMed X Institute and Merck KGaA, Darmstadt, Germany, extend collaboration in Oncology

Corporate News Updates; Pharma Feb 3rd 2022

View
12 Nov

Pandemic not over: Germany reports record 50,000 new Covid cases

Germany experiences a new wave of Covid-19

View
28 Aug

Coffee may reduce risk of death from stroke and heart disease

The latest research on coffee suggests the results are not the same for normal and decaff coffee

View
02 Aug

GSK and Vir Biotechnology announce joint procurement agreement with European Commission for COVID-19 treatment, Sotrovimab

Latest pharma news update

View
09 Jul

BioMed X and Merck KGaA, Darmstadt, Germany launch new research program in Oncology

Pharma News Update July 8

View
03 Jul

Germany issues world's strongest recommendation for mixing Covid-19 vaccines

Mixing vaccines are safe says Germany

View
19 May

European Union's drugs regulator says, Pfizer COVID vaccine can now be stored at fridge temperature for up to a month

Now Pfizer vaccines would ave extended shelf life

View
08 May

Roche’s Tecentriq approved by European Commission for metastatic non-small cell lung cancer

Tecentriq is now the first and only single-agent cancer immunotherapy with three dosing options

View

-Advertisements-




Trending Now

Maternal and Infant Health in Focus as India Observes World Health Day 2025April 05, 2025
Under 15 Children Under Threat: The TB Comeback No One Saw Coming April 04, 2025
MGM Healthcare Performs World's First Modified Multi-Visceral Transplant for Rare Intestinal DisorderApril 04, 2025
World Health Day 2025: St. George’s University’s Role in Preparing Doctors to Tackle Global Health ChallengesApril 04, 2025
Strength Doesn’t Retire: The Science Behind Ageless PowerApril 04, 2025
Beyond the Baby Bump: Can Delayed Pregnancy Increase Autism Risk in ChildrenApril 04, 2025
University of Manchester invites applications for MA Social AnthropologyApril 03, 2025
Ahead of World Health Day, Sova Health Launches Advanced Microbiome Tests & Evidence-Based Precision Supplements April 03, 2025
Half of women cannot make decisions about their reproductive health and bodily autonomyApril 03, 2025
UGRO CAPITAL LIMITED PUBLIC ISSUE OF SECURED, RATED, LISTED, REDEEMABLE, NON-CONVERTIBLE DEBENTURES (SECURED NCDS) OPENS TODAY EFFECTIVE ANNUALIZED YIELD UP TO 11.01% PER ANNUM* April 03, 2025
SF Airlines Entrusts Çelebi India with Freighter Handling at Kempegowda International Airport, BengaluruApril 03, 2025
Is This the Future of Physiotherapy? Inside Stance Health’s $1M ExpansionApril 03, 2025
The Daily Shower Debate: Are You Washing Away Your Skin’s Health?April 03, 2025
The Digital Sleep Thief: How Night-time Screen Addiction is Robbing You of Bed-time RestApril 02, 2025
KKR Launches ‘Knight Bite’ – A Digital Series That Serves Up Food, Fun, and Cricket!April 02, 2025
Crompton rolls out its all new range of Aura, Avancer & Jedi Air Coolers for an effortless summer cooling experienceApril 02, 2025
CARE Hospitals, Hi-Tech City Strengthens Orthopaedics Department with Renowned SurgeonsApril 02, 2025
World Autism Awareness Day: Breaking the Chains of Stigma in IndiaApril 02, 2025
From Scroll to Squint: How Reels Are Reshaping Your VisionApril 02, 2025
Moscow Center for Diagnostics and Telemedicine Receives License for Radiology Residency ProgramApril 02, 2025